ConductScience.org, home

Paper31444481

Protozoan persister-like cells and drug treatment failure.

Barrett MP and 4 others. Nat Rev Microbiol, 2019. Cited by 119 papers, by iCite.

Cite this record

ConductScience Library. Protozoan persister-like cells and drug treatment failure. Papers, record 31444481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31444481

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Protozoan persister-like cells and drug treatment failure.
PubMed
Journal
Nat Rev Microbiol
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
119
iCite
Relative citation ratio, by iCite
5.99
iCite
Revised in PubMed
2026-11-02
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiprotozoal AgentsMajor topic
Drug ToleranceMajor topic
LeishmaniaMajor topic
PlasmodiumMajor topic
ToxoplasmaMajor topic
Trypanosoma cruziMajor topic
Biological Variation, Population
Chagas Disease
Humans
Leishmaniasis
Malaria
Toxoplasmosis
Treatment Failure

Source PubMed

Download CSV of topics

Grants10

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI143857NIAID NIH HHSUnited StatesR01AI143857PubMedNIH RePORTER
R01 AI164473NIAID NIH HHSUnited StatesR01AI164473PubMedNIH RePORTER
MR/S019650/1Medical Research CouncilUnited KingdomPubMedPubMed
R21 AI144591NIAID NIH HHSUnited StatesR21AI144591PubMed and NIHNIH RePORTER
MR/L018853/1Medical Research CouncilUnited KingdomPubMedPubMed
R21 AI109530NIAID NIH HHSUnited StatesR21AI109530PubMed and NIHNIH RePORTER
R01 AI118426NIAID NIH HHSUnited StatesR01AI118426PubMed and NIHNIH RePORTER
R01 AI034036NIAID NIH HHSUnited StatesR01AI034036PubMed and NIHNIH RePORTER
Wellcome TrustUnited KingdomPubMedPubMed
R01AI124692NIHNIH RePORTER

Download CSV of grants

References152

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129743474A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum.Nat Commun2018https://conductscience.org/library/papers/29743474PubMed
225502314Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates.Science2015https://conductscience.org/library/papers/25502314PubMed
329241041Inhibiting the Plasmodium eIF2α Kinase PK4 Prevents Artemisinin-Induced Latency.Cell Host Microbe2017https://conductscience.org/library/papers/29241041PubMed
420133198Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination.Trends Parasitol2010https://conductscience.org/library/papers/20133198PubMed
58542997Plasmodium falciparum: recrudescence of parasites in culture.Exp Parasitol1995https://conductscience.org/library/papers/8542997PubMed
629602951A latent ability to persist: differentiation in Toxoplasma gondii.Cell Mol Life Sci2018https://conductscience.org/library/papers/29602951PubMed
723768488Microbial persistence and the road to drug resistance.Cell Host Microbe2013https://conductscience.org/library/papers/23768488PubMed
811897575Malaria parasites giving rise to recrudescence in vitro.Antimicrob Agents Chemother2002https://conductscience.org/library/papers/11897575PubMed
928831944Biological factors that impinge on Chagas disease drug development.Parasitology2017https://conductscience.org/library/papers/28831944PubMed
1028673423Chagas disease.Lancet2018https://conductscience.org/library/papers/28673423PubMed
1121126543The Apicomplexan AP2 family: integral factors regulating Plasmodium development.Mol Biochem Parasitol2011https://conductscience.org/library/papers/21126543PubMed
1224438211Toxoplasma development - turn the switch on or off?Cell Microbiol2014https://conductscience.org/library/papers/24438211PubMed
1319064625Evidence of artemisinin-resistant malaria in western Cambodia.N Engl J Med2008https://conductscience.org/library/papers/19064625PubMed
1424572359A cascade of DNA-binding proteins for sexual commitment and development in Plasmodium.Nature2014https://conductscience.org/library/papers/24572359PubMed
158397917Toxoplasmosis in the non-AIDS immunocompromised host.Curr Clin Top Infect Dis1993https://conductscience.org/library/papers/8397917PubMed
1626350965Novel Approaches Reveal that Toxoplasma gondii Bradyzoites within Tissue Cysts Are Dynamic and Replicating Entities In Vivo.mBio2015https://conductscience.org/library/papers/26350965PubMed
1729578409Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure.Elife2018https://conductscience.org/library/papers/29578409PubMed
1826694030Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum.Nat Commun2015https://conductscience.org/library/papers/26694030PubMed
1920160056Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/20160056PubMed
2030001347Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas' disease drug discovery.PLoS Negl Trop Dis2018https://conductscience.org/library/papers/30001347PubMed

See all 152 referencesDownload CSV of references

Cited by89

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.

PMIDTitleJournalYearIn PapersSource
42973691Complex I inhibition collapses host bioenergetics and activates p53-dependent apoptosis in Theileria annulata infected cells.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42973691PubMed
42832560Active transcriptome remodeling underlies antimony-induced drug tolerance in persister-like Leishmania parasites.PLoS Pathog2026https://conductscience.org/library/papers/42832560PubMed
42625565NN-assisted image analysis for quantifying intracellular Trypanosoma cruzi infection.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42625565PubMed
42603444Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay.Int J Parasitol Drugs Drug Resist2026https://conductscience.org/library/papers/42603444PubMed
42340977Beyond resistance: Emerging methods to dissect drug responses in Leishmania.PLoS Pathog2026https://conductscience.org/library/papers/42340977PubMed
42286211Multi-drug tolerance in Leishmania persister-like cells.Commun Biol2026https://conductscience.org/library/papers/42286211PubMed
42221541Trypanosomatid parasites, translational research in a One Health, One World environment.Front Chem2026https://conductscience.org/library/papers/42221541PubMed
42213660Leishmania major virulence attenuation in vitro: An old conundrum revisited in the omics era.PLoS Negl Trop Dis2026https://conductscience.org/library/papers/42213660PubMed
42185256Trypanosoma cruzi cell atlas as a single-cell resource for understanding parasite population heterogeneity and differentiation.Nat Commun2026https://conductscience.org/library/papers/42185256PubMed
42129552SNOR promotes translation restart after dormancy.Nature2026https://conductscience.org/library/papers/42129552PubMed
42108536A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate.J Antimicrob Chemother2026https://conductscience.org/library/papers/42108536PubMed
41929147A Novel Eukaryotic Ribosome Factor Enables Translation Restart Following Cellular Dormancy.bioRxiv2026https://conductscience.org/library/papers/41929147PubMed
41915614In Vivo Trypanocidal Activity of the Drug Disulfiram Combined with Benznidazole.ACS Infect Dis2026https://conductscience.org/library/papers/41915614PubMed
41888558Nonlinear dynamics of Nosema ceranae and the fragile resilience of honeybee colonies under environmental strain.Sci Rep2026https://conductscience.org/library/papers/41888558PubMed
41839971Unravelling complex interactions during Toxoplasma, Plasmodium, and Leishmania co-infections in French Guiana.Sci Rep2026https://conductscience.org/library/papers/41839971PubMed
41676625High throughput quantitative tracking of Plasmodium falciparum clonal blood stage parasite growth and applications for antimalarial drug discovery.bioRxiv2026https://conductscience.org/library/papers/41676625PubMed
41557738Untargeted metabolomics for triaging of cytochrome b inhibitors during Chagas' disease drug discovery.PLoS Negl Trop Dis2026https://conductscience.org/library/papers/41557738PubMed
40906736BFD2 mediates inflammation, apoptosis, and pre-anxiety-like behaviors induced by acute Toxoplasma gondii infection.PLoS Negl Trop Dis2025https://conductscience.org/library/papers/40906736PubMed
40699059Beyond the first case of Chagas disease: the Berenice strain as a model for understanding long-term Trypanosoma cruzi infection.Mem Inst Oswaldo Cruz2025https://conductscience.org/library/papers/40699059PubMed
40482566The importance of persistence and dormancy in Trypanosoma cruzi infection and Chagas disease.Curr Opin Microbiol2025https://conductscience.org/library/papers/40482566PubMed

See all 89 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AQP1358PubTator's text mininghttps://conductscience.org/library/genes/358NCBI Gene
EIF2A83939PubTator's text mininghttps://conductscience.org/library/genes/83939NCBI Gene
G6PD2539PubTator's text mininghttps://conductscience.org/library/genes/2539NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31444481

GET https://conductscience.org/api/papers/v1/31444481/references?page=2